Novo Nordisk in India marked the company’s 100^th global anniversary in a grand event on 16th February 2023 in Bengaluru and reaffirmed its commitment to providing care for people with diabetes, haemophilia, and other chronic diseases through its ’Driving Change for Generations’ campaign.

On this occasion, the company launched a digital employee community outreach portal aimed at encouraging employees to volunteer for community service and give back to the society. 

The digital community outreach portal will enable all employees to make significant contributions through their time, efforts, and skills. They will be able to collaborate with non-profit organisations across the nation, virtually or in-person. 

As part of its centennial celebrations, Novo Nordisk set up a digital heritage gallery tracing back its rich historical milestones in the field of pharmaceutical innovations and breakthroughs.

The official foundation date of Novo Nordisk is 16 February 1923. This combines two defining moments in the company’s history: (i) the establishment of Nordisk Insulinlaboratorium in 1923,  and (ii) the day Novo Terapeutisk Laboratorium introduced its first insulin on 16 February 1925.

The company kicked-off a century of advancement in protein-based medicines for those living with debilitating chronic conditions. Novo Nordisk insulins have been available in India since 1935, spanning more than 80 years. In the last one year, the company has achieved major milestones in the country including the launch of GLP-1 RA in oral form, a game-changer in diabetes management. 

With an aim to improve access to diabetes care in India, Novo Nordisk Education Foundation (NNEF) has also established various Centres of Excellence (CoEs) in collaboration with several public institutions including the Government of Karnataka; Indira Gandhi Medical College, Bangalore; Osmania Medical College, Hyderabad; Gandhi Medical College, Hyderabad; Government Institute of Medical Sciences (GIMS), Greater Noida, King George Medical College, Lucknow, and Aligarh Muslim University (AMU), Aligarh. The company has also launched CDiC programmes in India to help underprivileged children and young adults with Type 1 diabetes by providing them with the necessary care.

Image caption (L-R) : Vikrant Shrotriya , CVP & MD, Novo Nordisk India; Freddy Svane, Ambassador at the Royal Danish Embassy in New Delhi, Kapil Dev, former Indian cricketer and Brand Ambassador for Novo Nordisk India , Dr K M Prasanna Kumar, Renowned endocrinologist and Type 1 Diabetes expert; John Dawber, Corporate Vice President and Managing Director, Novo Nordisk Global Business Services.